
Scientists seek to study eDNA to identify how MSX creeps up on oysters
It's all part of the latest efforts to examine multinucleate sphere unknown, a parasite commonly referred to as MSX.
The new research would examine the genetic material, or environmental DNA, left behind by the parasite and any other intermediate hosts. Scientists believe this can help them understand more about how MSX behaves in the water and where it goes.
'It'll give us a whole lot more information about the parasite, what the parasite is doing, how long parasites last,' said Rod Beresford, an associate professor at Cape Breton University's biology department.
Beresford is among a group of scientists in Nova Scotia, New Brunswick and P.E.I. who have obtained $800,000 from various sources including Genome Atlantic, Genome Canada and provincial governments for two years, starting this summer, to study MSX using eDNA.
While their research is likely years away from practical applications, scientists say it could make it easier to protect oysters from deadly outbreaks that have left farmers in the lurch.
The single-celled MSX has been wreaking havoc on oysters for about 60 years. It was first found in Delaware Bay, near New Jersey, in 1957 and was detected in Bras d'Or Lake, Nova Scotia, in 2002. It has since been found in Prince Edward Island, New Brunswick and southern British Columbia.
The parasite targets cultured and wild oysters, and kills about 95 per cent of affected mollusks within two to three years of infection, and prevents them from reaching their full size. However, it poses no risk to human health or food safety.
In most cases, the fishing industry will often observe the parasite after oysters have started dying, Beresford said.
But scientists say the new research may identify how to get earlier warnings about potential outbreaks.
By learning more about the parasite's eDNA, scientists believe it could solve a mystery about its life cycle, said Ryan Carnegie, a shellfish pathologist at Virginia Institute of Marine Science.
'That's the primary application to addressing this mystery of the life cycle,' he said.
Environmental DNA can be detected in an environment sample such as sea water, Carnegie explained. But he said it cannot be detected in individual organisms such as shellfish.
The widespread use of eDNA began in the early aughts and an article in the journal, Bioscience in 2021, said this tool is becoming more widespread because it requires tiny amounts of genetic samples, is reliable and non-invasive.
Beresford said scientists could use eDNA to identify intermediate hosts of the MSX before it infects oysters. Intermediate hosts could be anything from tiny plankton, snails, worms, fish or other organisms on the sea floor.
Although he said it would likely be impossible to remove those intermediate hosts, he explained scientists might be able to collect information about them in order to predict when an outbreak might occur or assess whether any oysters are resistant to the parasite.
'We don't know if it takes a lot of MSX particles for an infection to take place, or if it only takes a little bit,' Beresford said.
Wednesdays
Columnist Jen Zoratti looks at what's next in arts, life and pop culture.
The research could be particularly welcomed by farmers in an industry that is worth millions of dollars. Overall, Statistics Canada data from 2023 shows the oyster aquaculture industry was valued at $17.8 million in Prince Edward Island, $3.7 million in Nova Scotia, $25.9 million in New Brunswick and $16 million in British Columbia.
While the parasite threatens to wipe out some of that value, the new research could be a lifeline for some farmers.
Bob MacLeod, president of the P.E.I. Shellfish Association, said he hopes the research is successful.
'If they ever figure out the intermediate host or a way to kind of get around the host … it would be a real plus for us. Because right now, this many years later from when it hit the States, they haven't figured it out.'
This report by The Canadian Press was first published June 5, 2025.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Cision Canada
04-07-2025
- Cision Canada
Detections of MSX and Dermo in oysters in Quebec
OTTAWA, ON, July 4, 2025 /CNW/ - The Canadian Food Inspection Agency (CFIA) has confirmed the presence of the aquatic animal diseases multinucleate sphere unknown (MSX) and Dermo (also known as Perkinsosis) in oyster samples collected in Chaleur Bay, Québec. MSX and Dermo do not pose risks to human health or food safety, but they can cause increased oyster mortality and decreased growth rates. These are the first confirmed cases of MSX and Dermo in Quebec. To limit the spread of the diseases, the CFIA, Fisheries and Oceans Canada (DFO) and the province of Quebec are working together with partners to monitor the situation and take necessary action. These actions are part of the Government of Canada's One Health approach to prepare for, detect, and manage animal diseases. In addition to existing robust protective measures and increased animal surveillance, the CFIA, in collaboration with DFO and the province of Quebec, continues to conduct tracing activities and testing of oysters to gain insight into the presence of MSX and Dermo in the area. Response measures include: applying movement controls to oysters, further investigating the potential source of the detections, engaging scientists, producers and harvesters to continue to monitor mollusc health, including notifying CFIA or the province of sick oysters or when decreased rates of growth or increased mortalities are observed, and ensuring that information regarding detection and movement control information is available to producers. Quick Facts MSX and Dermo pose no risk to human health and are not food safety concerns. Haplosporidium nelsoni causes multinucleate sphere unknown (MSX) in cultured and wild American oysters (Crassostrea virginica). Perkinsus marinus causes Perkinsosis (also known as Dermo) in cultured and wild American oysters (Crassostrea virginica). These diseases do not affect other bivalves in this area, including mussels, scallops, or clams; however, they can cause increased oyster mortality and decreased growth rates. With MSX, it is presumed there is an unknown intermediary host which makes it harder to determine how it is spread. Dermo can be transmitted from oyster to oyster, or from water contaminated with the parasite. Canada's National Aquatic Animal Health Program (NAAHP), co-delivered by the CFIA and Fisheries and Oceans Canada (DFO), is responsible for preventing the introduction and/or spread of significant aquatic animal diseases of finfish, molluscs and crustaceans. Facebook: CFIACanada X: @InspectionCan YouTube: @CFIA Instagram: @CFIA_Canada LinkedIn: Canadian Food Inspection Agency Each day, hard-working Canadian Food Inspection Agency employees—including inspectors, veterinarians, and scientists—inspect food for safety risks, work to protect plants from pests and invasive species, and respond to animal diseases that could threaten Canada's animal resource base and human health. Guided by science-based decision-making and modern regulations, the Agency verifies that food sold in Canada is safe while supporting access to international markets for our high-quality agricultural products. To learn more, visit


Cision Canada
26-06-2025
- Cision Canada
Major Investment from Genome Canada to Help Advance ClarityDX Prostate Adoption Across Canada
Funding to Propel Widespread Adoption and Integration of Innovative Prostate Cancer Diagnostic Test into Canadian Healthcare EDMONTON, AB, June 26, 2025 /CNW/ - Nanostics Inc., a precision health company developing diagnostic tests with its ClarityDX® platform technology, announced today significant financial support from Genome Canada and Genome Alberta through the Canadian Biotechnology Innovation and Commercialization Initiative (CBIC) to accelerate the integration of ClarityDX Prostate into the standard of care for prostate cancer screening across Canada. This project is propelled by academic, clinical, and economic collaborations with leadership from Dr. John Lewis, Bird Dogs Chair in Translational Oncology at the University of Alberta, Partnerships and Innovation at Acute Care Alberta (formerly Alberta Health Services), and Nanostics. ClarityDX Prostate is a laboratory-developed test that uses machine learning to combine clinical and blood-based biomarker data to predict the risk of aggressive, clinically significant prostate cancer and is currently offered as a patient-pay test. This pivotal funding will further support the adoption of ClarityDX Prostate into the standard of care for prostate cancer screening, first in Alberta, then across Canada. The anticipated outcome of this project is a stronger, more responsive, and cost-effective healthcare system for Canadians facing the challenge of prostate cancer. The project's primary objective is to assemble a comprehensive evidence package demonstrating the clinical efficacy and economic value of incorporating ClarityDX Prostate into Canada's prostate cancer diagnostic pathway. This evidence will help pave the way for reimbursement and increased public accessibility. The evidence package will include results from a clinical utility study, a health impact feasibility study, and a health system integration study. "We are very grateful for Genome Canada's support of this project," said Dr. John Lewis, Bird Dogs Chair of Translational Oncology. "This unique opportunity to collaborate directly with Acute Care Alberta will accelerate adoption of ClarityDX Prostate, and more importantly, help improve the outcomes of men in their journey of screening and diagnosis for prostate cancer." "This project is an example of how Acute Care Alberta is collaborating with academia, industry, and care providers to ensure that Albertans have access to the best quality healthcare," said Tara Klassen Ph.D., Innovation Lead - Surgical Care Alberta "The results from this real-world study will be used to quantify the impact of adopting ClarityDX Prostate into the Alberta and Canadian healthcare systems using in system, on system, for systems science." About ClarityDX Prostate ® and How to Order the Test ClarityDX Prostate uses biological data, clinical information, and AI-powered learning models to generate a risk score for aggressive prostate cancer, marking a significant advancement in prostate cancer screening. It provides critical support to men and their healthcare providers in making more informed decisions about whether to proceed with a biopsy following a high prostate-specific antigen (PSA) test result or an abnormal digital rectal exam (DRE).


CBC
10-06-2025
- CBC
Oyster harvesters in P.E.I. fear overfishing, empty rivers next spring amid MSX concerns
More than 80 of the Island's wild oyster harvesters had to find new places to fish after the MSX parasite forced the shutdown of Bedeque Bay last year. As CBC's Nancy Russell reports, the pressure to find more oysters has meant some rivers are being fished out — and that could mean no catches next spring.